Nutex Health Inc. (NUTX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

-350M 0 350M 700M 1.1B Q1 '14: 1.3M Q2 '14: 1.2M Q1 '15: 1.1M Q2 '15: 1.2M Q3 '15: 1.2M Q4 '16: 0 Q1 '17: -399.4K Q2 '17: -394.8K Q3 '17: -375.8K Q4 '18: 1.4M Q1 '19: 1.6M Q2 '19: 2M Q3 '19: 2.2M Q4 '19: 1.4M Q1 '20: 1.6M Q2 '20: 1.6M Q3 '20: 1.7M Q4 '20: 274M Q1 '21: 275.6M Q2 '21: 338M Q3 '21: 455.6M Q4 '21: 246.2M Q1 '22: 323.3M Q2 '22: 318.5M Q3 '22: 229M Q4 '22: 219.3M Q1 '23: 196.5M Q2 '23: 197.4M Q3 '23: 231.7M Q4 '23: 247.6M Q1 '24: 258.8M Q2 '24: 275.9M Q3 '24: 292M Q4 '24: 479.9M Q1 '25: 624.3M Q2 '25: 792.2M Q3 '25: 981.2M Q4 '25: 875.3M Q1 '26: 880M Q2 '26: 846.7M Q3 '15 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit TTM

-200M 0 200M 400M 600M Q3 '15: 656.7K Q4 '16: 0 Q1 '17: -396.4K Q2 '17: -406.2K Q3 '17: -395.2K Q4 '17: -7.3K Q1 '18: -15.2K Q2 '18: -9.6K Q3 '18: -5.9K Q4 '18: 859.4K Q1 '19: 906.8K Q2 '19: 1M Q3 '19: 1.1M Q4 '19: 536K Q1 '20: 758.8K Q2 '20: 754.3K Q3 '20: 782.2K Q4 '20: 157.6M Q1 '21: 157.8M Q2 '21: 186.8M Q3 '21: 262.7M Q4 '21: 125.1M Q1 '22: 160.4M Q2 '22: 137.9M Q3 '22: 38.2M Q4 '22: 19.3M Q1 '23: -11.7M Q2 '23: -8.7M Q3 '23: 22.1M Q4 '23: 34.8M Q1 '24: 40.1M Q2 '24: 53M Q3 '24: 67.8M Q4 '24: 196.3M Q1 '25: 304.4M Q2 '25: 406.8M Q3 '25: 539.8M Q4 '25: 444.3M Q1 '26: 417.7M Q2 '26: 434M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Income TTM

-450M -300M -150M 0 150M 300M 450M Q3 '16: -486.3K Q4 '16: -448.6K Q1 '17: -449.9K Q2 '17: -1.6M Q3 '17: -2.3M Q4 '17: -5.7M Q1 '18: -5.9M Q2 '18: -5.2M Q3 '18: -4.8M Q4 '18: -840.4K Q1 '19: -1.4M Q2 '19: -2.4M Q3 '19: -2.9M Q4 '19: -6.9M Q1 '20: -6.9M Q2 '20: -4.8M Q3 '20: -2.1M Q4 '20: 153.2M Q1 '21: 150M Q2 '21: 176.9M Q3 '21: 249.6M Q4 '21: 113.5M Q1 '22: 146.8M Q2 '22: 117.9M Q3 '22: -385.3M Q4 '22: -406.6M Q1 '23: -440.3M Q2 '23: -439.3M Q3 '23: -11.4M Q4 '23: -31.8M Q1 '24: -25.9M Q2 '24: -20.2M Q3 '24: -9.7M Q4 '24: 130.6M Q1 '25: 209.8M Q2 '25: 238.2M Q3 '25: 358.9M Q4 '25: 275.6M Q1 '26: 276.2M Q2 '26: 364.3M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Net Income TTM

-600M -400M -200M 0 200M 400M 600M Q3 '15: -533.1K Q4 '16: -7.4M Q1 '17: -7.4M Q2 '17: -9M Q3 '17: -2.9M Q4 '17: 582.1K Q1 '18: 214.1K Q2 '18: 1.1M Q3 '18: -5.8M Q4 '18: -950.1K Q1 '19: -1.3M Q2 '19: -2.2M Q3 '19: -2.5M Q4 '19: -7.1M Q1 '20: -7.3M Q2 '20: -5.4M Q3 '20: -2.8M Q4 '20: 106M Q1 '21: 102.6M Q2 '21: 132.1M Q3 '21: 204.8M Q4 '21: 132.6M Q1 '22: 158.5M Q2 '22: 109.6M Q3 '22: -377.1M Q4 '22: -424.8M Q1 '23: -451.4M Q2 '23: -435.6M Q3 '23: -28.9M Q4 '23: -45.8M Q1 '24: -41M Q2 '24: -37.9M Q3 '24: -41.1M Q4 '24: 52.2M Q1 '25: 73.8M Q2 '25: 56.4M Q3 '25: 120.7M Q4 '25: 70.8M Q1 '26: 96.4M Q2 '26: 179.9M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue TTM

-6M 0 6M 12M 18M Q4 '10: 391.6K Q1 '11: 473.9K Q2 '11: 599.1K Q3 '11: 690.7K Q4 '11: 764.7K Q1 '12: 889.6K Q2 '12: 890.5K Q3 '12: 862.8K Q4 '12: 783.5K Q1 '13: 644.2K Q2 '13: 571.3K Q1 '14: 483.1K Q2 '14: 457.2K Q1 '15: 498K Q2 '15: 541.8K Q3 '15: 552.4K Q4 '16: 0 Q1 '17: -3K Q2 '17: 11.4K Q3 '17: 19.4K Q4 '17: 30.5K Q1 '18: 38.2K Q2 '18: 31.7K Q3 '18: 31.6K Q4 '18: 507.6K Q1 '19: 668.2K Q2 '19: 987.3K Q3 '19: 1.1M Q4 '19: 830.4K Q1 '20: 861.1K Q2 '20: 798.9K Q3 '20: 926.5K Q4 '20: 909.8K Q1 '21: 2.3M Q2 '21: 6.2M Q3 '21: 10.4M Q4 '21: 14.6M Q1 '22: 17.6M Q2 '11 Q3 '12 Q2 '14 Q1 '17 Q2 '18 Q3 '19 Q4 '20 Q1 '22

Operating Cash Flow TTM

-100M 0 100M 200M 300M Q3 '15: -348.1K Q4 '15: -290K Q1 '16: -452.6K Q2 '16: -393.8K Q3 '16: -342.6K Q4 '16: -274.2K Q1 '17: -116.5K Q2 '17: -418.2K Q3 '17: -597.2K Q4 '17: -714.6K Q1 '18: -863.1K Q2 '18: -839K Q3 '18: -903.8K Q4 '18: -765.5K Q1 '19: -1.4M Q2 '19: -2M Q3 '19: -2.6M Q4 '19: -4M Q1 '20: -4M Q2 '20: -3.7M Q3 '20: -3M Q4 '20: 86.7M Q1 '21: 87M Q2 '21: 190.8M Q3 '21: 215.2M Q4 '21: 173.4M Q1 '22: 209.7M Q2 '22: 124.1M Q3 '22: 92.5M Q4 '22: 50.6M Q1 '23: 15.9M Q2 '23: -1.7M Q3 '23: 7.5M Q4 '24: 23.2M Q1 '25: 71.1M Q2 '25: 85.1M Q3 '25: 177.8M Q4 '25: 248.1M Q1 '26: 272.7M Q2 '26: 279.6M Q3 '16 Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '22 Q1 '25 Q2 '26

Free Cash Flow TTM

-100M 0 100M 200M 300M Q4 '11: -678.5K Q1 '12: -425.9K Q2 '12: -319.3K Q3 '12: -385.7K Q4 '12: -526.7K Q4 '14: 162.6K Q1 '15: 36.9K Q2 '15: -579.2K Q3 '15: -353.1K Q4 '15: -291.8K Q4 '20: 25.5M Q1 '21: 25.8M Q2 '21: 107.9M Q3 '21: 128.8M Q4 '21: 136.5M Q1 '22: 164.2M Q2 '22: 92.2M Q3 '22: 58.3M Q4 '24: 20.8M Q1 '25: 69.4M Q2 '25: 83.2M Q3 '25: 176.3M Q4 '25: 245.6M Q1 '26: 269M Q2 '26: 274.2M Q4 '11 Q4 '12 Q3 '15 Q2 '21 Q2 '22 Q2 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 250M 500M 750M Q2 '10: 24M Q2 '11: 24M Q1 '13: 25M Q2 '13: 25M Q3 '13: 25M Q1 '14: 25M Q2 '14: 25.4M Q2 '14: 25.4M Q3 '14: 26.7M Q2 '15: 26.9M Q3 '15: 27.8M Q1 '16: 39.7M Q1 '17: 48.8M Q2 '21: 592.8M Q3 '21: 592.8M Q1 '22: 592.8M Q2 '22: 646.4M Q3 '22: 654.8M Q1 '23: 43.4M Q2 '23: 656.6M Q3 '23: 4.4M Q1 '24: 4.8M Q2 '24: 5M Q3 '24: 5.1M Q1 '25: 6.5M Q2 '25: 6M Q3 '25: 7.2M Q1 '26: 7.2M Q2 '26: 7M Q2 '10 Q3 '13 Q3 '14 Q1 '17 Q2 '22 Q3 '23 Q1 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-18.00 -9.00 0.00 9.00 18.00 27.00 Q1 '13: -0.07 Q2 '13: -0.04 Q1 '15: -0.05 Q2 '15: -0.05 Q3 '15: -0.04 Q4 '15: 0.00 Q1 '16: 0.00 Q2 '16: 0.00 Q3 '16: 0.00 Q4 '16: -0.19 Q1 '17: -0.18 Q2 '17: -0.21 Q3 '17: -0.15 Q4 '17: 0.01 Q1 '18: 0.00 Q2 '18: 0.02 Q3 '18: -2.13 Q4 '19: -1.97 Q1 '20: -1.83 Q2 '20: -1.34 Q3 '20: -0.78 Q4 '20: -1.17 Q1 '21: -1.17 Q2 '21: -1.17 Q3 '21: -1.42 Q4 '21: -0.08 Q1 '22: 0.20 Q2 '22: 0.12 Q3 '22: -0.59 Q4 '22: -0.63 Q1 '23: -0.79 Q2 '24: -8.87 Q3 '24: -9.34 Q4 '24: 9.25 Q1 '25: 12.66 Q2 '25: 9.78 Q3 '25: 19.26 Q4 '25: 9.75 Q1 '26: 12.94 Q2 '26: 25.27 Q3 '15 Q4 '16 Q1 '18 Q2 '20 Q3 '21 Q4 '22 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.